173 related articles for article (PubMed ID: 31915968)
21. In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells.
Gadi VK; Alexander SD; Kudlow JE; Allan P; Parker WB; Sorscher EJ
Gene Ther; 2000 Oct; 7(20):1738-43. PubMed ID: 11083495
[TBL] [Abstract][Full Text] [Related]
22. Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy.
Xie X; Guo J; Kong Y; Xie GX; Li L; Lv N; Xiao X; Tang J; Wang X; Liu P; Yang M; Xie Z; Wei W; Spencer DM; Xie X
J Gene Med; 2011 Dec; 13(12):680-91. PubMed ID: 22009763
[TBL] [Abstract][Full Text] [Related]
23. Antitumor effects of a dual-specific lentiviral vector carrying the Escherichia coli purine nucleoside phosphorylase gene.
Wang X; Sun L; Sun X; Yu J; Wang K; Wu Y; Gao Q; Zheng J
Int J Oncol; 2017 May; 50(5):1612-1622. PubMed ID: 28393254
[TBL] [Abstract][Full Text] [Related]
24. Phosphorolytic cleavage of 2-fluoroadenine from 9-beta-D-arabinofuranosyl-2-fluoroadenine by Escherichia coli. A pathway for 2-fluoro-ATP production.
Huang P; Plunkett W
Biochem Pharmacol; 1987 Sep; 36(18):2945-50. PubMed ID: 3307790
[TBL] [Abstract][Full Text] [Related]
25. Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer.
Martiniello-Wilks R; Wang XY; Voeks DJ; Dane A; Shaw JM; Mortensen E; Both GW; Russell PJ
J Gene Med; 2004 Dec; 6(12):1343-57. PubMed ID: 15493036
[TBL] [Abstract][Full Text] [Related]
26. Intratumoral generation of 2-fluoroadenine to treat solid malignancies of the head and neck.
Behbahani TE; Rosenthal EL; Parker WB; Sorscher EJ
Head Neck; 2019 Jun; 41(6):1979-1983. PubMed ID: 30633420
[TBL] [Abstract][Full Text] [Related]
27. Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease.
Martiniello-Wilks R; Dane A; Voeks DJ; Jeyakumar G; Mortensen E; Shaw JM; Wang XY; Both GW; Russell PJ
J Gene Med; 2004 Jan; 6(1):43-54. PubMed ID: 14716676
[TBL] [Abstract][Full Text] [Related]
28. Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine.
Ungerechts G; Springfeld C; Frenzke ME; Lampe J; Johnston PB; Parker WB; Sorscher EJ; Cattaneo R
Cancer Res; 2007 Nov; 67(22):10939-47. PubMed ID: 18006839
[TBL] [Abstract][Full Text] [Related]
29. Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine.
Deharvengt S; Rejiba S; Wack S; Aprahamian M; Hajri A
Int J Oncol; 2007 Jun; 30(6):1397-406. PubMed ID: 17487360
[TBL] [Abstract][Full Text] [Related]
30. PNP anticancer gene therapy.
Zhang Y; Parker WB; Sorscher EJ; Ealick SE
Curr Top Med Chem; 2005; 5(13):1259-74. PubMed ID: 16305530
[TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamics and proposed mechanism of therapeutic action and host toxicity of 9-beta-D-arabinofuranosyl-2-fluoroadenine monophosphate (F-araAMP) in P388 murine leukemia-bearing mice.
Avramis VI
Cancer Invest; 1989; 7(2):129-37. PubMed ID: 2477118
[TBL] [Abstract][Full Text] [Related]
32. Designer gene therapy using an Escherichia coli purine nucleoside phosphorylase/prodrug system.
Bennett EM; Anand R; Allan PW; Hassan AE; Hong JS; Levasseur DN; McPherson DT; Parker WB; Secrist JA; Sorscher EJ; Townes TM; Waud WR; Ealick SE
Chem Biol; 2003 Dec; 10(12):1173-81. PubMed ID: 14700625
[TBL] [Abstract][Full Text] [Related]
33. Purine nucleoside phosphorylase from Pseudoalteromonas sp. Bsi590: molecular cloning, gene expression and characterization of the recombinant protein.
Li X; Jiang X; Li H; Ren D
Extremophiles; 2008 May; 12(3):325-33. PubMed ID: 18299797
[TBL] [Abstract][Full Text] [Related]
34. Suicide gene/prodrug therapy for pancreatic adenocarcinoma by E. coli purine nucleoside phosphorylase and 6-methylpurine 2'-deoxyriboside.
Deharvengt S; Wack S; Uhring M; Aprahamian M; Hajri A
Pancreas; 2004 Mar; 28(2):E54-64. PubMed ID: 15028961
[TBL] [Abstract][Full Text] [Related]
35. Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene.
Hughes BW; Wells AH; Bebok Z; Gadi VK; Garver RI; Parker WB; Sorscher EJ
Cancer Res; 1995 Aug; 55(15):3339-45. PubMed ID: 7614469
[TBL] [Abstract][Full Text] [Related]
36. Suicide gene/prodrug therapy using salmonella-mediated delivery of Escherichia coli purine nucleoside phosphorylase gene and 6-methoxypurine 2'-deoxyriboside in murine mammary carcinoma 4T1 model.
Fu W; Lan H; Liang S; Gao T; Ren D
Cancer Sci; 2008 Jun; 99(6):1172-9. PubMed ID: 18429958
[TBL] [Abstract][Full Text] [Related]
37. Design and evaluation of 5'-modified nucleoside analogs as prodrugs for an E. coli purine nucleoside phosphorylase mutant.
Parker WB; Allan PW; Ealick SE; Sorscher EJ; Hassan AE; Silamkoti AV; Fowler AT; Waud WR; Secrist JA
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):387-92. PubMed ID: 16247956
[TBL] [Abstract][Full Text] [Related]
38. Dual specific antitumor effects of Semliki Forest virus-based DNA vector carrying suicide Escherichia coli purine nucleoside phosphorylase gene via Salmonella.
Chen ZH; Huang GL; Tu YQ; Jiang Y; Dai WX
Int J Oncol; 2013 Jun; 42(6):2009-18. PubMed ID: 23588611
[TBL] [Abstract][Full Text] [Related]
39. Neuroblastoma-specific cytotoxicity mediated by the Mash1-promoter and E. coli purine nucleoside phosphorylase.
Arvidsson Y; Sumantran V; Watt F; Uramoto H; Funa K
Pediatr Blood Cancer; 2005 Jan; 44(1):77-84. PubMed ID: 15390277
[TBL] [Abstract][Full Text] [Related]
40. Antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine, a novel deoxyadenosine analog, against human colon tumor xenografts by oral administration.
Takahashi T; Kanazawa J; Akinaga S; Tamaoki T; Okabe M
Cancer Chemother Pharmacol; 1999; 43(3):233-40. PubMed ID: 9923554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]